77 related articles for article (PubMed ID: 412076)
21. Production of monoclonal antibodies using spleen cells from nude mice bearing human tumors.
Al Saati T; Blancher A; Calvas P; Neulat-Duga I; Delsol G
Ann Pathol; 1987; 7(1):1-8. PubMed ID: 3040026
[TBL] [Abstract][Full Text] [Related]
22. [Tumor associated antigens induce humoral and cellular immune response to laryngeal carcinomas (author's transl)].
Zenner HP; Herrmann IF
Laryngol Rhinol Otol (Stuttg); 1979 Nov; 58(11):865-70. PubMed ID: 529958
[TBL] [Abstract][Full Text] [Related]
23. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin.
Avner B; Swindell L; Sharp E; Liao SK; Ogden JR; Avner BP; Oldham RK
Mol Biother; 1991 Mar; 3(1):14-21. PubMed ID: 2069755
[TBL] [Abstract][Full Text] [Related]
24. [The search for circulating immune complex (IC) (author's transl)].
Verroust P
Ann Biol Clin (Paris); 1980; 38(6):333-43. PubMed ID: 7011116
[TBL] [Abstract][Full Text] [Related]
25. [Recent advances in the study of metastases].
Carter RL
Recenti Prog Med; 1973 May; 54(5):404-21. PubMed ID: 4581375
[No Abstract] [Full Text] [Related]
26. Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anti-carcinoembryonic antigen antibodies.
Tsujisaki M; Imai K; Tokuchi S; Hanzawa Y; Ishida T; Kitagawa H; Hinoda Y; Yachi A
Cancer Res; 1991 May; 51(10):2599-604. PubMed ID: 2021940
[TBL] [Abstract][Full Text] [Related]
27. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
[TBL] [Abstract][Full Text] [Related]
28. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
[TBL] [Abstract][Full Text] [Related]
29. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
30. [Quantitative analysis of immune complexes and assessment of autorosette-forming cells in patients with malignant disease (author's transl)].
Betzler M; Schiebe A; Herfarth C
Chir Forum Exp Klin Forsch; 1980; ():309-13. PubMed ID: 7389471
[TBL] [Abstract][Full Text] [Related]
31. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
32. [Cryosurgery of lung metastases (author's transl)].
Largiadèr F; Uhlschmid G; Gattiker HH
Thoraxchir Vask Chir; 1975 Dec; 23(6):515-22. PubMed ID: 1082659
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
35. [In vivo study of antitumor immune responses induced by anti-idiotypic minibody vaccine of ovarian cancer].
Chang XH; Cui H; Feng J; Yang WL; Li Y; Fu TY
Ai Zheng; 2004 Jul; 23(7):777-81. PubMed ID: 15248911
[TBL] [Abstract][Full Text] [Related]
36. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
Erez-Alon N; Herkel J; Wolkowicz R; Ruiz PJ; Waisman A; Rotter V; Cohen IR
Cancer Res; 1998 Dec; 58(23):5447-52. PubMed ID: 9850078
[TBL] [Abstract][Full Text] [Related]
37. [Immunological aspect of metastasis of ovarian cancer].
Mandai M; Hamanishi J; Abiko K; Yoshioka Y; Konishi I
Nihon Rinsho; 2012 Jun; 70 Suppl 4():507-11. PubMed ID: 23156299
[No Abstract] [Full Text] [Related]
38. [New technique of circulating immunocomplex estimation in human sera (author's transl)].
Hasková V; Kaslík J; Matl I; Matĕjcková M
Cas Lek Cesk; 1977 Apr; 116(14):436-7. PubMed ID: 161727
[No Abstract] [Full Text] [Related]
39. Immunologic factors in experimental metastases formation.
Fidler IJ
Int J Radiat Oncol Biol Phys; 1975; 1(1-2):93-6. PubMed ID: 1233373
[No Abstract] [Full Text] [Related]
40. [Association between tumor immunology, stromal reaction, and tumor endocarditis (author's transl)].
Stosiek P
Virchows Arch A Pathol Anat Histol; 1975 Dec; 369(2):143-53. PubMed ID: 129944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
